Manufacturing

Apr 01, 2005
BioPharm International
By BioPharm International Editors
Mass serialization, or the ability to store a unique serial number for each item, is the most useful feature of RFID tags.
Mar 01, 2005
BioPharm International
Bioterrorism legislation is in the works, but there will be a tough fight to enact added liability protections for manufacturers.
Feb 01, 2005
BioPharm International
By BioPharm International Editors
Unfortunately, once circuits are commissioned and validated, optimizing — or even adjusting — them is difficult and rarely done because of the time and effort required for revalidation.
Feb 01, 2005
BioPharm International
By BioPharm International Editors
In most production environments, it is critical to be able to associate historical environmental data with process data.
Feb 01, 2005
BioPharm International
By BioPharm International Editors
Disposable products and systems have come a long way since they first entered the small-lab market in the 1970s. Today they are available for practically every aspect of biopharmaceutical manufacturing. Disposable systems are used for filtration, clarification, purification, and separation applications used in the production of vaccines, monoclonal antibodies, and other therapies. As the use of disposable systems grows, the concept of a completely disposable manufacturing process is becoming a reality.
Oct 01, 2004
BioPharm International
By BioPharm International Editors
Identifying issues in the factory that traditionally arise in the field minimized onsite equipment rework and subsequent qualification work.
Oct 01, 2004
BioPharm International
By BioPharm International Editors
Wyeth BioPharma has identified cycle-time reduction as critical to customer responsiveness and the success of commercial and pipeline products. In formulating a plan of attack, the company focused on two aspects of cycle time: the global planning process and disposition cycle times.
Sep 01, 2004
BioPharm International
By BioPharm International Editors
The objective of the feasibility stage is to determine whether the proposed biotechnological process can be executed.
Apr 01, 2004
BioPharm International
FDA backs e-chips over paper pedigrees and unit-of-use packaging.
Mar 01, 2004
BioPharm International
By BioPharm International Editors
Using disposable components for bioprocessing can reduce costs and complexity and may play an increasing role in large-scale biopharmaceutical manufacturing.
native1_300x100
lorem ipsum